Crossmark

Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend

Crossref DOI link: https://doi.org/10.1016/j.endinu.2018.03.009

Published Print: 2018-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gómez, Ana María

Henao, Diana Cristina

Imitola, Angelica

Muñoz, Oscar Mauricio

Sepúlveda, Martín Alonso Rondón

Kattah, Laura

Guerrero, Juan Sebastian

Morros, Elly

Llano, Juan Pablo

Jaramillo, Maira García

León-Vargas, Fabián
Funding

Funding for this research was provided by:

Medtronic

Novo Nordisk

Abbott Laboratories

Novartis
License Information

Text and Data Mining valid from 2018-10-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend

Journal Title: Endocrinología, Diabetes y Nutrición

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endinu.2018.03.009

Content Type: article

Copyright: © 2018 SEEN y SED. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below